All In Biotech

Drug Trial Radar · NCT02413346

A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris

Last checked: Nov 20, 2026Latest source record: Feb 1, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

490

Actual

Start

Mar 20, 2015

Primary completion

Aug 26, 2016

Study completion Aug 26, 2016

Sponsor

Lead sponsor
Almirall, S.A.Industry
Sponsor type
Industry
Collaborators
Allergan
First posted
Apr 9, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 9 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Open-label study will evaluate the safety of an approximate 1.5 mg/kg/day dose of oral sarecycline in the long-term treatment of participants with moderate to severe facial acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

  • SarecyclineDrug

    Administered based on participant's body weight.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With at Least 1 Treatment-Emergent Adverse Event (TEAE)Time frame: Up to 40 Weeks

Locations

56 sites in 1 country. Site status is shown where the registry gives one.

  • Actavis Investigational Study Site #206

    Mobile, Alabama

  • Actavis Investigational Study Site #236

    Hot Springs, Arkansas

  • Actavis Investigational Study Site #245

    Carlsbad, California

  • Actavis Investigational Study Site #129

    Encino, California

  • Actavis Investigational Study Site #209

    Fremont, California

  • Actavis Investigational Study Site #147

    Sacramento, California

  • Actavis Investigational Study Site #150

    San Diego, California

  • Actavis Investigational Study Site #125

    San Diego, California

  • Actavis Investigational Study Site #204

    San Diego, California

  • Actavis Investigational Study Site #222

    Denver, Colorado

  • Actavis Investigational Study Site #148

    Wheat Ridge, Colorado

  • Actavis Investigational Study Site #226

    Clearwater, Florida

  • Actavis Investigational Study Site #238

    Jupiter, Florida

  • Actavis Investigational Study Site #249

    Miami, Florida

  • Actavis Investigational Study Site #145

    Miami, Florida

  • Actavis Investigational Study Site #211

    Miramar, Florida

  • Actavis Investigation Study Site # 140

    North Miami Beach, Florida

  • Actavis Investigational Study Site #151

    Orange, Florida

  • Actavis Investigational Study Site #203

    Tampa, Florida

  • Actavis Investigational Study Site #242

    Snellville, Georgia

  • Actavis Investigational Study Site #124

    Boise, Idaho

  • Actavis Investigational Study Site #106

    Chicago, Illinois

  • Actavis Investigational Study Site #113

    South Bend, Indiana

  • Actavis Investigational Study Site #213

    Louisville, Kentucky

  • Actavis Investigational Study Site #217

    Rockville, Maryland

  • Actavis Investigational Study Site #251

    Clarkston, Michigan

  • Actavis Investigational Study Site #235

    Clinton Township, Michigan

  • Actavis Investigational Study Site #227

    Fort Gratiot, Michigan

  • Actavis Investigational Study Site #111

    Warren, Michigan

  • Actavis Investigational Study Site #221

    Fridley, Minnesota

  • Actavis Investigational Study Site #231

    Omaha, Nebraska

  • Actavis Investigational Study Site #146

    New York, New York

  • Actavis Investigational Study Site #208

    New York, New York

  • Actavis Investigational Study Site #240

    Rochester, New York

  • Actavis Investigational Study Site #230

    Stony Brook, New York

  • Actavis Investigational Study Site #229

    Raleigh, North Carolina

  • Actavis Investigational Study Site #149

    Gresham, Oregon

  • Actavis Investigational Study Site #257

    Philadelphia, Pennsylvania

  • Actavis Investigational Study Site #225

    Goodlettsville, Tennessee

  • Actavis Investigational Study Site #128

    Knoxville, Tennessee

Showing 40 of 56 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.